ZHU:CA:TSX-BMO Equal Weight US Health Care (CAD)

COMMON STOCK | |

Last Closing

CAD 42.22

Change

0.00 (0.00)%

Market Cap

CAD 0.05B

Volume

100.00

Analyst Target

N/A
Analyst Rating

Verdict

ducovest Verdict

Verdict

About

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2024-05-08 )

Largest Industry Peers for

Symbol Name Price(Change) Market Cap
TD-PFB:CA Toronto Dominion Bank Pref B

-0.10 (-0.41%)

CAD 195.27B
TD-PFD:CA Toronto Dominion Bank Pref D

-0.05 (-0.21%)

CAD 162.58B
TD-PFI:CA Toronto-Dominion Bank Pref Ser..

+0.15 (+0.59%)

CAD 160.00B
TD-PFM:CA Toronto-Dominion Bank Pref Ser..

+0.01 (+0.04%)

CAD 141.82B
ENB-PFA:CA Enbridge Inc Pref 9

-0.11 (-0.60%)

CAD 111.14B
ENB-PFV:CA Enbridge Inc Pref 5

+0.15 (+0.68%)

CAD 110.48B
ENB-PFC:CA Enbridge Inc Pref 11

-0.08 (-0.46%)

CAD 105.63B
ENB-PFG:CA Enbridge Inc Pref 15

N/A

CAD 100.73B
ENB-PFU:CA Enbridge Inc Pref L

+0.19 (+0.91%)

CAD 81.76B
PPL-PFA:CA Pembina Pipeline Corp Pref Ser..

-0.25 (-1.10%)

CAD 9.28B

ETFs Containing ZHU:CA

N/A

Market Performance

  Market Performance vs. Industry/Classification () Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 3.10% N/A N/A 41% F
Dividend Return N/A N/A N/A N/A N/A
Total Return 3.10% N/A N/A 37% F
Trailing 12 Months  
Capital Gain -0.92% N/A N/A 32% F
Dividend Return N/A N/A N/A N/A N/A
Total Return -0.92% N/A N/A 26% F
Trailing 5 Years  
Capital Gain 40.69% N/A N/A 66% D+
Dividend Return N/A N/A N/A N/A N/A
Total Return 40.69% N/A N/A 60% D-
Average Annual (5 Year Horizon)  
Capital Gain 7.42% N/A N/A 68% D+
Dividend Return 7.42% N/A N/A 63% D
Total Return N/A N/A N/A N/A N/A
Risk Return Profile  
Volatility (Standard Deviation) 13.28% N/A N/A 59% D-
Risk Adjusted Return 55.85% N/A N/A 80% B-
Market Capitalization 0.05B N/A N/A 27% F

Annual Financials (CAD)

Quarterly Financials (CAD)

Analyst Rating

Target Price Action Rating Action Analyst Rating Price Date

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:

There is nothing we particularly like

What to not like:

There is nothing we particularly dislike